VIDEO: Brian Carlin, MD, FCCP, Discusses Challenges in Reducing Readmission Rates
Brian Carlin, MD, FCCP, Allegheny General Hospital, discusses the challenges in reducing 30-day readmission rates, specifically as they apply to congestive heart failure, pneumonia, and COPD. The biggest challenge of all is setting up a coordinated team care effort, says Dr Carlin.
This video was taken on Monday, October 22 at the CHEST 2012 conference in Atlanta, GA.
Readmissions are one of the many Achilles’ heels of healthcare. Whether it is a failure in communication, problems with medication adherence, or an overall lack of quality healthcare delivery, readmissions cause many headaches within the system. Saturday at the American College of Cardiology 62nd Annual Scientific Session and Expo featured a discussion on successful transitions of care to help prevent readmissions.
Technology continues to advance at such an incredible pace that it can be hard for many industries to keep up with the ways in which new systems and processes can help them be more effective. In this morning’s session, “Your Next Provider Will Be an Avatar,” presenter Thomas Morrow, MD, explained why it’s necessary for the healthcare industry to not only keep pace with technological innovations, but also to integrate these technologies into several aspects of care.
Check out photos from this year's conference in Atlanta, GA, which took place from October 20-25. The meeting was held at the Georgia World Congress Center, which sits between CNN headquarters and the Georgia Dome.
Although there has been a concentrated focus on pulmonary vascular diseases at this year’s CHEST conference, there have also been a number of studies released that pertain to cardiovascular events, such as congestive heart failure, atrial fibrillation, and chronic obstructive pulmonary disease. Here are some of the highlights in these areas.
Although there have been a wide variety of disease states covered at this year’s CHEST conference, much of the focus has been on those under the umbrella of pulmonary vascular disease, such as pulmonary arterial hypertension and deep vein thrombosis. Here are some of the new study highlights related to pulmonary vascular disease.